The most common mechanisms of resistance to ALK inhibition in NSCLC are reported to involve bypass signaling through functionally-related pathways, such that cells grow in an ALK-independent manner when the kinase is inhibited21. Here, ALK is linked to non-small cell lung carcinoma.